home.aspx

 
.

USING GENOMICS TO ACCELERATE DRUG DEVELOPMENT FOR NEURODEGENERATIVE DISEASES

March 26, 2020 | (09:00am)
USA (United States of America)
SHARESHARESHARE
Drug targets with human genetic evidence of disease association are twice as likely to lead to approval (King et al. 2019). But navigating the millions of genetic data points to comprehensively identify genomic drivers of a target indication or drug pathway is daunting. Understanding the molecular drivers of disease accelerates drug development at each stage of the process. It...